Vera Mikhaylovna Kosman

Vera Mikhaylovna Kosman

Auto-generated profile, based on publicly available information

Vera Mikhaylovna Kosman

Research-and-manufacturing company “HOME OF PHARMACY

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
OPOlga N. Pozharitskaya
Olga N. Pozharitskaya
ASAlexander B. Schikov
Alexander B. Schikov
NFNatalya M. Faustova
Natalya M. Faustova
EOEkaterina Obluchinskaya
Ekaterina Obluchinskaya
VKVera M. Kosman
Vera M. Kosman
VMValery G. Makarov
Valery G. Makarov
Fucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysaccharide found in Fucus (F.) vesiculosus. The pharmacokinetic profiling of active compounds is essential for drug development and approval. The aim of the study was to evaluate the pharmacokinetics and tissue distribution of fucoidan in rats after a single-dose oral administration. Fucoidan was isolated from F. vesiculosus. The method of measuring anti-activated factor X (anti-Xa) activity by amidolytic assay was used to analyze the plasma and tissue concentrations of fucoidan. The tissue distribution of fucoidan after intragastric administration to the rats was characterized, and it exhibited considerable heterogeneity. Fucoidan preferentially accumulates in the kidneys (AUC0–t = 10.74 µg·h/g; Cmax = 1.23 µg/g after 5 h), spleen (AUC0–t = 6.89 µg·h/g; Cmax = 0.78 µg/g after 3 h), and liver (AUC0–t = 3.26 µg·h/g; Cmax = 0.53 µg/g after 2 h) and shows a relatively long absorption time and extended circulation in the blood, with a mean residence time (MRT) = 6.79 h. The outcome of this study provides additional scientific data for traditional use of fucoidan-containing plants and offers tangible support for the continued development of new effective pharmaceuticals using fucoidan.

16 April 2020 in Molecules
Verified
Journal Article
Open access
PDF file
ASAlexander B. Schikov
Alexander B. Schikov
VKVera M. Kosman
Vera M. Kosman
EFElena V. Flissyuk
Elena V. Flissyuk
ISIrina E. Smekhova
Irina E. Smekhova
Abdelhameed ElameenAbdelhameed Elameen
Abdelhameed Elameen
OPOlga N. Pozharitskaya
Olga N. Pozharitskaya
The extraction of Rhodiola rosea rhizomes using natural deep eutectic solvent (NADES) consisting of lactic acid, glucose, fructose, and water was investigated. A two-level Plackett–Burman design with five variables, followed by the steepest ascent method, was undertaken to determine the optimal extraction conditions. Among the five parameters tested, particle size, extraction modulus, and water content were found to have the highest impact on the extrability of phenyletanes and phenylpropanoids. The concentration of active compounds was analyzed by HPLC. The predicted results showed that the extraction yield of the total phenyletanes and phenylpropanoids (25.62 mg/g) could be obtained under the following conditions: extraction time of 154 min, extraction temperature of 22 °C, extraction modulus of 40, molar water content of 5:1:11 (L-lactic acid:fructose:water, mol/mol), and a particle size of rhizomes of 0.5–1 mm. These predicted values were further verified by validation experiments in predicted conditions. The experimental yields of salidroside, tyrosol, rosavin, rosin, cinnamyl alcohol and total markers (sum of phenyletanes and phenylpropanoids in mg/g) were 11.90 ± 0.02, 0.36 ± 0.02, 12.23 ± 0.21, 1.41 ± 0.01, 0.20 ± 0.01, and 26.10 ± 0.27 mg/g, respectively, which corresponded well with the predicted values from the models.

30 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Abdelhameed ElameenAbdelhameed Elameen
Abdelhameed Elameen
VKVera M. Kosman
Vera M. Kosman
MTMette Goul Thomsen
Mette Goul Thomsen
OPOlga N. Pozharitskaya
Olga N. Pozharitskaya
ASAlexander B. Schikov
Alexander B. Schikov
Rhodiola rosea L. (roseroot) is an adaptogen plant belonging to the Crassulaceae family. The broad spectrum of biological activity of R. rosea is attributed to its major phenyletanes and phenylpropanoids: rosavin, salidroside, rosin, cinnamyl alcohol, and tyrosol. In this study, we compared the content of phenyletanes and phenylpropanoids in rhizomes of R. rosea from the Norwegian germplasm collection collected in 2004 and in 2017. In general, the content of these bioactive compounds in 2017 was significantly higher than that observed in 2004. The freeze-drying method increased the concentration of all phenyletanes and phenylpropanoids in rhizomes compared with conventional drying at 70 °C. As far as we know, the content of salidroside (51.0 mg g−1) observed in this study is the highest ever detected in Rhodiola spp. Long-term vegetative propagation and high genetic diversity of R. rosea together with the freeze-drying method may have led to the high content of the bioactive compounds observed in the current study.

11 October 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ASAlexander B. Schikov
Alexander B. Schikov
OPOlga N. Pozharitskaya
Olga N. Pozharitskaya
NFNatalia M. Faustova
Natalia M. Faustova
VKVera M. Kosman
Vera M. Kosman
VMValery G. Makarov
Valery G. Makarov
JNJohannes Novak
Johannes Novak
A glycopeptide fraction (GPF) from internal organs of green sea urchins (Strongylocentrotus droebachiensis Müller, Strongylocentrotidae) has been reported to be an effective bronchitis treatment. In this study, we evaluated the pharmacokinetic and tissue distribution of GPF, following single and repeated intranasal (i/n) administration over the course of seven days in rats. The method measuring lactate dehydrogenase as biomarker was used to analyse the plasma and tissue concentrations of GPF. GPF appears in the plasma 15 min after single i/n administration (100 µg/kg) and reaches its maximum at 45 min. The area under the curve (AUC)0–24 and Cmax were similar using both i/n and intravenous administration, while mean residence time (MRT) and T1/2 after i/n administration were significantly higher compared with intravenous (i/v) administration. The absolute bioavailability of GPF after i/n administration was 89%. The values of tissue availability (ft) provided evidence about the highest concentration of GPF in the nose mucosa (ft = 34.9), followed by spleen (ft = 4.1), adrenal glands (ft = 3.8), striated muscle (ft = 1.8), kidneys (ft = 0.5), and liver (ft = 0.3). After repeated dose administration, GPF exhibited significantly higher AUC0–24 and MRT, indicating its accumulation in the plasma.

1 May 2025 in Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
MKM. V. Karlina
M. V. Karlina
VKV. M. Kosman
V. M. Kosman
MMM. N. Makarova
M. N. Makarova
VMV. G. Makarov
V. G. Makarov
INTRODUCTION. Quality by design (QbD) is a systematic approach to pharmaceu­tical development that begins with predefined objectives and emphasises product and process understanding and process control, based on sound science and quality risk management. The QbD approach facilitates the production of medicinal products with target characteristics and quality profiles. There are currently no specific guidelines for the application of QbD principles to the development of individual dosage forms.AIM. This study aimed to evaluate the possibility of and propose an algorithm for using QbD at the laboratory stage of pharmaceutical development for solid dosage forms, with tablets as a case study.MATERIALS AND METHODS. This study analysed publicly available regulatory documents, scientific publications, and guidelines on pharmaceutical development using general scientific methods, including comparative and logical analysis. The regula­tory documents analysed included those issued by the International Council for Harmonisation (ICH), the Eurasian Economic Commission, and the State Pharmacopoeia of the Russian Federation. The sources searched included electronic databases, such as PubMed, Web of Science, eLIBRARY.RU, and Google Scholar.RESULTS. Developing the quality target product profile (QTPP) and composition of tablets requires a comprehensive study of the active substance, as well as an assessment of its compatibility with the excipients. At the laboratory stage of pharmaceu­tical development, it is necessary to select and optimise the medicinal product composition while assessing potential risks. This approach provides for the preliminary identification of critical quality attributes, critical process parameters, and critical material parameters. This article presents an algorithm for applying QbD to tablet formulations at the laboratory stage of pharmaceutical development.CONCLUSIONS. When implemented at the laboratory stage, the proposed algorithm with QbD elements will improve the overall efficiency of pharmaceutical development.

9 November 2022 in Reviews on Clinical Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
VKVera M. Kosman
Vera M. Kosman
MKMarina V. Karlina
Marina V. Karlina
KTKsenia V. Tyutina
Ksenia V. Tyutina
VMValery G. Makarov
Valery G. Makarov
MMMarina N. Makarova
Marina N. Makarova
ГЕГущина Евгения Евгеньевна
Гущина Евгения Евгеньевна
BACKGROUND: Phenosanic acid is a synthetic antioxidant, the active ingredient of the original domestic drug recommended for the treatment of epilepsy. To improve the effectiveness and safety of the use of phenosanoic acid, additional study of its pharmacokinetic properties is necessary. AIM: To study the pharmacokinetic parameters of the active ingredient of the drug Dibufelon, capsule 200 mg (LLC Piq-Pharma, Russia) in vitro and in vivo systems in rats after single administration in one dose. MATERIALS AND METHODS: Phenosanic acid binding to blood plasma proteins, microsomal stability and permeability through the monolayer of Caco-2 cells were evaluated in in vitro tests. The pharmacokinetics parameters were studied after a single intragastric administration in Wistar rats in dose of 80 mg/kg. The samples were analyzed by HPLC-UV. RESULTS: A high variability in the degree of binding of phenosanic acid to blood plasma proteins by 2065% depending on the concentration was revealed, relatively high microsomal stability (half-life 1106 789 min, internal clearance 2.05 0.86 l/min/mg protein of liver microsome; residual content after 60 min incubation 87.9 7.8%) and the ability to penetrate through the monolayer of cells Caco-2. The rapid absorbtion of the substance into the systemic bloodstream was established its maximum concentration in blood plasma was observed already 3.6 1.2 hours after administration, and its slow removal from the systemic bloodstream the half-life was about 19 h, the average retention time was about 29 h. Phenosanic acid with different degrees of intensity was distributed to all the examined organs and tissues: kidneys liver brain omentum muscle, and invariably excreted in a small amount with urine and feces, about 0.04% and 5.5%, respectively. CONCLUSIONS: As a result of the study, it was found that phenosanic acid is characterized by rapid absorbtion into the systemic bloodstream and a long stay in it invariably, which may be due to the peculiarities of its binding to blood plasma proteins and relatively high metabolic stability, revealed during the corresponding in vitro tests. The study of the permeability and transport of phenosanic acid showed that it can presumably be attributed to compounds with medium permeability and is not a substrate for the transport protein P-glycoprotein (P-gp). The study of tissue availability of phenosanic acid confirmed its entry into peripheral tissues, including the brain, which is the area of implementation of the anticonvulsant effect.